Search
for
Sort by
Research 301–330 of 1000+
- HAIR AND SYSTEMATIC DISEASE
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- TOXIC EPIDERMAL NECROLYSIS
- 5α-Reduced glucocorticoids: a story of natural selection
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Cicatricial (Scarring) Alopecias
- Adverse Cutaneous Reactions to Antidepressants
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Conversion of the Nipple to Hair-Bearing Epithelia by Lowering Bone Morphogenetic Protein Pathway Activity at the Dermal-Epidermal Interface
- Update on the dermatologic use of systemic glucocorticosteroids
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Acquired scalp alopecia. Part II: A review
- Toxic shock syndrome: Recent developments in pathogenesis
- Circulatory Changes in Alopecia
- Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
- Stress and Psychoneuroimmunologic Factors in Dermatology
- Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- The Basic Science of Hair Biology
- Innovative Uses for Zinc in Dermatology
- Frontal Fibrosing Alopecia: A Retrospective Analysis of 72 Patients from a German Academic Center
- Frontal fibrosing alopecia: a case series of 65 patients seen in a single Italian centre
- Unraveling the Molecular Mechanisms of Hair and Nail Genodermatoses
- Cicatricial Alopecia Research Foundation meeting, May 2016: Progress towards the diagnosis, treatment and cure of primary cicatricial alopecias
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations